Evidence map›Paper›PMID 32695682›Full record

ArticleFrontiers in oncology2020

Metabolic and OXPHOS Activities Quantified by Temporal

Andre Koit, Natalja Timohhina, Laura Truu, Vladimir Chekulayev, Shivakumar Gudlawar, Igor Shevchuk, Katrin Lepik, Lea Mallo, Riina Kutner, Vahur Valvere and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Andre KoitChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
Natalja TimohhinaChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
Laura TruuChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
Vladimir ChekulayevChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
Shivakumar GudlawarChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
Igor ShevchukChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
Katrin LepikOncology and Hematology Clinic at the North Estonia Medical Centre, Tallinn, Estonia.
Lea MalloOncology and Hematology Clinic at the North Estonia Medical Centre, Tallinn, Estonia.
Riina KutnerOncology and Hematology Clinic at the North Estonia Medical Centre, Tallinn, Estonia.
Vahur ValvereOncology and Hematology Clinic at the North Estonia Medical Centre, Tallinn, Estonia.
Tuuli KaambreChemical Biology Laboratory, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia.
National Institute of Chemical Physics and Biophysics · EENorth Estonia Medical Centre · EETallinn University · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research on mitochondrial metabolism and respiration are rapidly developing areas, however, efficient and widely accepted methods for studying these in solid tumors are still missing. Here, we developed a new method without isotope tracing to quantitate time dependent mitochondrial citrate efflux in cell lines and human breast cancer samples. In addition, we studied ADP-activated respiration in both of the sample types using selective permeabilization and showed that metabolic activity and respiration are not equally linked. Three times lower amount of mitochondria in scarcely respiring MDA-MB-231 cells convert pyruvate and glutamate into citrate efflux at 20% higher rate than highly respiring MCF-7 mitochondria do. Surprisingly, analysis of 59 human breast cancers revealed the opposite in clinical samples as aggressive breast cancer subtypes, in comparison to less aggressive subtypes, presented with both higher mitochondrial citrate efflux and higher respiration rate. Additionally, comparison of substrate preference (pyruvate or glutamate) for both mitochondrial citrate efflux and respiration in triple negative breast cancers revealed probable causes for high glutamine dependence in this subtype and reasons why some of these tumors are able to overcome glutaminase inhibition. Our research concludes that the two widely used breast cancer cell lines fail to replicate mitochondrial function as seen in respective human samples. And finally, the easy method described here, where time dependent small molecule metabolism and ADP-activated respiration in solid human cancers are analyzed together, can increase success of translational research and ultimately benefit patients with cancer.

Indexed as

ADP-activated respirationcancer metabolismcitrateglutaminolysismetabolic dependenciesmitochondrial fluxOXPHOSpredictive biomarker

Identifiers

PMID32695682
PMCPMC7339107
OpenAlexW3039376113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.